Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms.

O'Reilly EM

doi:10.1038/s41575-025-01170-9

← 뒤로

Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms.

0/5 보강

Nature reviews. Gastroenterology & hepatology 2026 Vol.23(2) p. 115-116

O'Reilly EM

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA O'Reilly EM (2026). Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms.. Nature reviews. Gastroenterology & hepatology, 23(2), 115-116. https://doi.org/10.1038/s41575-025-01170-9

MLA O'Reilly EM. "Pancreatic cancer: advances in immunology, translational analyses and therapeutic paradigms.." Nature reviews. Gastroenterology & hepatology, vol. 23, no. 2, 2026, pp. 115-116.

PMID 41513991

DOI 10.1038/s41575-025-01170-9

같은 제1저자의 인용 많은 논문 (1)

Clinical and translational results from a phase 1 trial of gemcitabine/nab-paclitaxel with nivolumab/ipilimumab or hydroxychloroquine/ipilimumab in untreated metastatic pancreatic adenocarcinoma.
Journal for immunotherapy of cancer 2026